{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:31:17Z","timestamp":1769869877856,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.pt.2003.11.006","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T15:38:08Z","timestamp":1069688288000},"page":"73-76","source":"Crossref","is-referenced-by-count":55,"title":["Drugs against leishmaniasis: a synergy of technology and partnerships"],"prefix":"10.1016","volume":"20","author":[{"given":"Antony J.","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry W.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Handman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2003.11.006_BIB1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3201\/eid0906.030026","article-title":"Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan","volume":"9","author":"Reithinger","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.pt.2003.11.006_BIB2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ije\/25.4.862","article-title":"The epidemic of visceral leishmaniasis in western upper Nile, southern Sudan: course and impact from 1984 to 1994","volume":"25","author":"Seaman","year":"1996","journal-title":"Int. J. Epidemiol."},{"issue":"Suppl. 1","key":"10.1016\/j.pt.2003.11.006_BIB3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0035-9203(01)90218-4","article-title":"Leishmaniasis in Sudan. Visceral leishmaniasis","volume":"95","author":"Zijlstra","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2003.11.006_BIB4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2003.11.006_BIB5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0924-8579(99)00133-8","article-title":"A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis","volume":"13","author":"Yardley","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.pt.2003.11.006_BIB6","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment of visceral leishmaniasis","volume":"45","author":"Murray","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2003.11.006_BIB7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis \u2013 current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2003.11.006_BIB8","series-title":"AIDS in the World","first-page":"825","article-title":"The next epidemic","author":"Garrett","year":"1992"},{"key":"10.1016\/j.pt.2003.11.006_BIB9","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1128\/AAC.47.8.2513-2517.2003","article-title":"Immunoenhancement combined with amphotericin B as treatment in experimental visceral leishmaniasis","volume":"47","author":"Murray","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2003.11.006_BIB10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrd1131","article-title":"Making better drugs: decision gates in non-clinical drug development","volume":"2","author":"Pritchard","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2003.11.006_BIB11","first-page":"422","article-title":"Drug target validation: hitting the target","author":"Smith","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pt.2003.11.006_BIB12","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.287.5460.1960","article-title":"Drug discovery: a historical perspective","volume":"287","author":"Drews","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pt.2003.11.006_BIB13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd1086","article-title":"Hit and lead generation: beyond high-throughput screening","volume":"2","author":"Bleicher","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2003.11.006_BIB14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"von Itzstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pt.2003.11.006_BIB15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/pmic.200300462","article-title":"Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani","volume":"3","author":"Bente","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.pt.2003.11.006_BIB16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/1615-9861(200208)2:8<1007::AID-PROT1007>3.0.CO;2-G","article-title":"A proteomic approach to identify developmentally regulated proteins in Leishmania infantum","volume":"2","author":"El Fakhry","year":"2002","journal-title":"Proteomics"},{"key":"10.1016\/j.pt.2003.11.006_BIB17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/1615-9861(200207)2:7<877::AID-PROT877>3.0.CO;2-D","article-title":"Establishing two-dimensional gels for the analysis of Leishmania proteomes","volume":"2","author":"Acestor","year":"2002","journal-title":"Proteomics"},{"key":"10.1016\/j.pt.2003.11.006_BIB18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1074\/mcp.M200085-MCP200","article-title":"Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms","volume":"2","author":"Drummelsmith","year":"2003","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.pt.2003.11.006_BIB19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd1063","article-title":"Designing screens: how to make your hits a hit","volume":"2","author":"Walters","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2003.11.006_BIB20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pt.2003.11.006_BIB21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1367-5931(99)80058-1","article-title":"Recognizing molecules with drug-like properties","volume":"3","author":"Walters","year":"1999","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.pt.2003.11.006_BIB22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/prot.10115","article-title":"Principles of docking: An overview of search algorithms and a guide to scoring functions","volume":"47","author":"Halperin","year":"2002","journal-title":"Proteins"},{"key":"10.1016\/j.pt.2003.11.006_BIB23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrd706","article-title":"High-throughput crystallography for lead discovery in drug design","volume":"1","author":"Blundell","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2003.11.006_BIB24","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/jm00034a001","article-title":"Application of the three-dimensional structures of protein target molecules in structure-based drug design","volume":"37","author":"Greer","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pt.2003.11.006_BIB25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nrd941","article-title":"Integration of virtual and high-throughput screening","volume":"1","author":"Bajorath","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2003.11.006_BIB26","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1021\/jm000472o","article-title":"Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design","volume":"44","author":"Bressi","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pt.2003.11.006_BIB27","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/anie.200200539","article-title":"Application and limitations of x-ray crystallographic data in structure-based ligand and drug design","volume":"42","author":"Davis","year":"2003","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"Suppl. 2","key":"10.1016\/j.pt.2003.11.006_BIB28","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1007\/s00436-002-0774-5","article-title":"Concepts of immunostimulation to increase antiparasitic drug action","volume":"90","author":"Masihi","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2003.11.006_BIB29","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2003.11.006_BIB30","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/IAI.71.11.6453-6462.2003","article-title":"Modulation of T cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis","volume":"71","author":"Murray","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2003.11.006_BIB31","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2003.11.006_BIB32","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2003.11.006_BIB33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrmicro727","article-title":"Where will new antibiotics come from?","volume":"1","author":"Walsh","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pt.2003.11.006_BIB34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/425225a","article-title":"Drug companies snub antibiotics as pipeline threatens to run dry","volume":"425","author":"Clarke","year":"2003","journal-title":"Nature"}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492203003180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492203003180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T19:00:02Z","timestamp":1550343602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492203003180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1471492203003180"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2003.11.006","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}